-transparent.png){kind=logo}
alpha-Neoendorphin (alpha-NEO) is a proenkephalin B-derived opioid peptide and kappa type opioid receptor agonist. In the present study, we used a combination of microdialysis and a highly sensitive radioimmunoassay to measure the extracellular levels of immunoreactive (ir)-alpha-NEO from the anterior pituitary gland of conscious free-moving rats. When rats were given water ad libitum under a 12:12 h light-dark cycle with lighting from 06.00 to 18.00 h, ir-alpha-NEO showed circadian rhythmicity that peaked at 00.00-03.00 h and reached a minimum at 12.00-15.00 h. Furthermore, we investigated whether naloxone (10(-6) to 10(-8) M) affected ir-alpha-NEO level. The alpha-NEO release induced by naloxone was optimum at 10(-7) M, and 10(-6) M naloxone seemed to induce alpha-NEO release to a lesser degree. These results suggested that alpha-NEO release by naloxone might be mediated via anterior pituitary cell auto-receptor (kappa type) inhibition.
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
April 1984,
Neuroscience letters,
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
June 1993,
Journal of neuroendocrinology,
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
March 1992,
Neuroendocrinology,
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
February 1978,
Life sciences,
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
January 1982,
Nihon rinsho. Japanese journal of clinical medicine,
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
January 1990,
Progress in clinical and biological research,
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
January 1987,
Proceedings of the National Academy of Sciences of the United States of America,
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
January 1994,
Acta biologica Hungarica,
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
March 1985,
Naunyn-Schmiedeberg's archives of pharmacology,
H Konya, and
H Masuda, and
K Nagai, and
E Kakishita
July 1987,
Life sciences,
